News Focus
News Focus
icon url

manibiotech

11/20/25 5:22 PM

#798939 RE: FeMike #798936

Lol :) . Wait for the next spin 
icon url

KevGee59

11/20/25 6:31 PM

#798968 RE: FeMike #798936

Welll this is awkward. Dr AI was wrong again? Man I feel shocked.


And what's worse is he usually gets 125 thumbs up on every AI post. No matter how ridiculous.

This kind of posting is way more detrimental than what the FUDsters posts, IMO. It just doesn't do anybody any good. Full stop.
icon url

StonkMaster

11/20/25 8:10 PM

#798996 RE: FeMike #798936

Apparently they are differentiating between clean rooms, suites and labs.
I have no clue.
icon url

dstock07734

11/21/25 12:56 AM

#799037 RE: FeMike #798936

You feel shocked? How so? I am certain what you have seen is not even called an appetizer.

Keep in mind the flaskworks system in the UK is only the first prototype. The second prototype which is considerably larger is going to be put in the facility that LP already selected. In fact, I don't pay too much attention to what happened in the UK. I know for sure that both Merck and Amgen wouldn't let sit idle their biologic manufacturing facility which they worked like hell to complete in light speed.

Have you seen how $NWBO can separate barnacle-like DCs without damaging them? Gently shaking the instrument with its vessel walls coated with special film from Zeon. That seems the way!

Did I point out the possibility that LP must have external help in tackling the issue of harvesting barnacle-like DCs without damaging them when LP first mentioned the barnacle nature of DCs? If it was something LP thought extremely difficult, then NWBO didn't have the financial resources and the professionals to solve it. External help should be the only way. That's why I figured it out. You and your buddies try to make things look complicated. The simple reality is that for this very investment all the longs need to know is how revolutionary the science is. Everything else is just the noise and LP will take care of it.

https://nwbio.com/northwest-biotherapeutics-moves-from-optimization-of-flaskworks-prototype-to-fabrication-of-gmp-compliant-units-for-installation-validation-and-final-testing-prior-to-regulatory-certification/

Flaskworks System.

During 2024, the Company’s Flaskworks team and Advent, together with a specialized external contractor, completed the design work for a GMP-compatible second prototype of its system for closed preparation of DCVax-L products. An initial prototype had been completed in 2023. The second prototype included upgraded functionality, however it was also considerably larger than the first prototype as a result, and the effect would be to reduce the number of systems that could fit in each Grade C lab and hence reduce the amount of products that could be produced. After further evaluations, the Company decided to go forward with the first prototype. The Company has arranged for another specialized external contractor (in the UK), has brought that contractor up to speed and has that contractor standing by to fabricate GMP units of the first prototype as soon as the Company is ready. The Flaskworks units will only be usable in the Grade C labs, and hence are not useful until the Grade C labs have been constructed, validated and are operational. Since the timeframe for fabricating the Flaskworks units is much shorter than the timeframe for buildout of the Grade C labs (including the simplified initial Grade C lab), the Company has been holding off on proceeding with the fabrication until closer to the time when the initial Grade C lab will be operational.



https://www.zeonsmi.com/about/news/zeon-invests-in-u-s-startup-solestial-to-accelerate-the-delivery-of-abundant-energy-in-space-2/